CE-SDS (capillary electrophoresis-sodium dodecyl sulfate) is a technique that separates proteins by size inside a thin capillary tube. It works on the same principle as traditional gel electrophoresis but replaces the slab gel with a liquid polymer matrix pumped through a capillary, making the process faster, more automated, and more quantitative. CE-SDS has become a standard tool in the biopharmaceutical industry for measuring the purity of therapeutic proteins, especially monoclonal antibodies.
How CE-SDS Separates Proteins
The technique relies on SDS, a detergent that unfolds (denatures) proteins and coats them with a uniform negative charge. When SDS binds to a protein, it creates a complex where the ratio of charge to mass is roughly the same regardless of the protein’s original shape or charge. This means the only thing distinguishing one protein from another during separation is size.
These SDS-protein complexes are then pulled through a sieving polymer inside a narrow capillary (typically 50 to 75 micrometers in diameter) by an electric field. Smaller proteins navigate through the polymer mesh faster, while larger ones move more slowly. A detector at the far end of the capillary records each protein as it passes, producing a trace of peaks that corresponds to the different-sized species in the sample.
What the Capillary System Looks Like
Instead of a permanent gel, CE-SDS uses a replaceable polymer solution that fills the capillary before each run. Common sieving polymers include linear polyacrylamide, polyethylene glycol, dextran, and polyethylene oxide. Because the polymer is pumped in fresh each time, you avoid the batch-to-batch variability that comes with casting individual slab gels. The capillary’s inner wall is typically coated with a layer of polyacrylamide to prevent proteins from sticking to the glass surface, which improves the consistency of results.
Detection happens in one of two ways. UV absorbance (usually at 220 nm) is the standard approach and works well for most routine analyses. For applications requiring higher sensitivity, laser-induced fluorescence (LIF) detection can be used after labeling proteins with a fluorescent dye. LIF detection has achieved detection limits as low as about 0.8 nanograms per milliliter for viral capsid proteins, with significantly higher signal intensity and resolution compared to UV detection.
Reducing vs. Non-Reducing Analysis
CE-SDS can be run under two conditions, each revealing different information about a protein sample.
In non-reducing CE-SDS, proteins are denatured with SDS but their disulfide bonds stay intact. This preserves the overall chain structure of the molecule, so you see the intact antibody along with any fragments that may have formed. Non-reduced analysis is used to measure monomeric purity and to quantify fragmentation, identifying partial antibodies that are missing one or both heavy or light chains.
In reducing CE-SDS, a chemical agent like dithiothreitol or beta-mercaptoethanol is added to break the disulfide bonds that hold protein chains together. A monoclonal antibody, for instance, separates into its individual heavy chains and light chains. This lets you measure the relative abundance of each chain, assess whether sugar molecules (glycans) are properly attached to the heavy chain, and detect any unusual bonded variants that resist reduction.
How It Compares to SDS-PAGE
Traditional SDS-PAGE (polyacrylamide gel electrophoresis) has been the workhorse of protein size analysis for decades. CE-SDS was developed as a direct upgrade and has been steadily replacing SDS-PAGE in biopharmaceutical labs for over 20 years. The key advantages come down to automation, quantitation, and throughput.
SDS-PAGE requires manual gel casting, staining, destaining, and visual or densitometric interpretation. CE-SDS automates nearly all of this. Samples are loaded and separated sequentially with minimal hands-on time, and the detector produces digital data that can be integrated directly for quantitative purity measurements. Migration times with coated capillaries are highly reproducible, with relative standard deviations as low as 0.2 to 0.5%, which is difficult to match with manual gels. CE-SDS also uses far less sample material per run.
One trade-off is that CE-SDS is not as reliable for determining exact molecular weight. The apparent molecular weight of glycosylated proteins can shift depending on the polymer matrix and running conditions, so the technique is used primarily for purity and relative size comparisons rather than precise mass assignment.
Where CE-SDS Is Used
The technique’s biggest footprint is in biopharmaceutical development and quality control. It is used commercially to generate quantitative purity data for therapeutic proteins, both during development and as part of lot release testing before a drug reaches patients.
For monoclonal antibodies specifically, CE-SDS serves as a workhorse characterization tool. It can detect and quantify clipping (where the antibody’s hinge region gets cut), assess product stability under stress conditions like heat or high pH, and distinguish between different types of degradation. Researchers have used it to characterize how metals like copper, iron, and zinc cause specific types of antibody fragmentation, information that guides how manufacturing processes are designed to avoid degradation.
Beyond antibodies, CE-SDS with LIF detection has been applied to newer therapeutic modalities like adeno-associated virus (AAV) vectors used in gene therapy, where it can quantify the purity of viral capsid proteins at very low concentrations.
What CE-SDS Measures in Practice
The output of a CE-SDS run is an electropherogram, a plot of detector signal over time. Each peak represents a protein species of a particular size. By integrating the area under each peak, analysts calculate the percentage of the total that each species represents. For a monoclonal antibody, the main peak is the intact molecule, and smaller peaks represent fragments, aggregates, or other impurities.
From non-reduced runs, the key measurement is monomeric purity: the percentage of the sample that consists of intact, properly assembled antibody. Fragment peaks are identified and quantified individually. From reduced runs, analysts calculate heavy chain and light chain relative abundance, glycan occupancy (what percentage of heavy chains carry their expected sugar modification), and the presence of any thioether-linked variants.
These measurements feed directly into regulatory filings and product specifications. Because CE-SDS is quantitative, automated, and reproducible, it provides the kind of consistent data that regulatory agencies expect when evaluating whether a biologic drug meets its quality standards.